Comparative Evaluation of Intraligamentary Injection of Dexamethasone, Diclofenac Sodium, and Chymotrypsin for Enhancing the Success of 4% Articaine Buccal Infiltration in Mandibular Molars With Symptomatic Irreversible Pulpitis

NCT07506265 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Irreversible Pulpitis (Toothache)

Interventions

DRUG: Dexamathsone 4mg/ml associated with experimental arm
DRUG: Diclofenac Sodium (DCS)
DRUG: chymotrypsin

Sponsor

Fayoum University